← Leaderboards
Jacob M Haus
University Of Illinois At Chicago
$3,536,275
Attributed
$3,536,275
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $647.3K · FY2016–24$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,536,275 · 2
By mechanism
R01$3,107,275 · 1
R21$429,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Dale Alan Pelligrino$6,075,166
- Margaret Schulz$212,958
- Roberto Machado$965,282
- John Varga$15,528,672
- Gnanasekar Munirathinam$862,067
Others in their field
Top investigators on “Acetylation”
- David A Bennett · Rush University Medical Center$25,513,948
- Shelley L Berger · University Of Pennsylvania$22,878,192
- Ming-Ming Zhou · Mount Sinai School Of Medicine Of Nyu$21,618,940
- Bing Ren · Ludwig Institute For Cancer Research$20,720,312
- Eric M Verdin · J. David Gladstone Institutes$19,319,184
- Melanie Maria Ott · J. David Gladstone Institutes$18,930,356
Research focus
AcetylationMuscleObesityNon-Insulin-Dependent Diabetes MellitusProductionTissuesFunctional OutcomesInflammatoryMetabolicMuscle FibersPhenotypePhosphorylationAdultSkeletal MuscleCellsDeacetylationInflammationGenerationsLysineMediatingMetabolismThinnessAdvanced Glycosylation End ProductsBinding
Grant awards (8)
Exploring regulatory mechanisms of glyoxalase-1$195,000
R21 · FY2024 · AG · contact PI
Exploring regulatory mechanisms of glyoxalase-1$234,000
R21 · FY2023 · AG · contact PI
Strategies and Functional Outcomes of Enhancing in Vivo Production of Soluble Rage Isoforms$613,936
R01 · FY2020 · DK · contact PI
Strategies and Functional Outcomes of Enhancing in Vivo Production of Soluble Rage Isoforms$614,386
R01 · FY2019 · DK · contact PI
Strategies and functional outcomes of enhancing in vivo production of soluble rage isoforms$601,591
R01 · FY2018 · DK · contact PI
Strategies and functional outcomes of enhancing in vivo production of soluble rage isoforms$373,778
R01 · FY2017 · DK · contact PI
Strategies and functional outcomes of enhancing in vivo production of soluble rage isoforms$273,506
R01 · FY2017 · DK · contact PI
Strategies and functional outcomes of enhancing in vivo production of soluble rage isoforms$630,078
R01 · FY2016 · DK · contact PI